Cognetivity Neurosciences Ltd. (CGNSF) Research

Cognetivity Neurosciences Ltd. is a healthcare firm focused on advanced cognitive assessment. The company has developed a sophisticated platform for cognitive testing, designed for use across diverse settings including medical facilities, commercial environments, and by individual consumers. This innovative system's primary goal is to identify the very first signs of cognitive impairment through a comprehensive evaluation of broad brain functions, thereby assisting in the diagnosis of conditions like dementia. In addition to its core platform, Cognetivity also provides OptiMind, a dedicated wellness application. Established in 2015, the company initially operated under the name Utor Capital Corp. before officially rebranding to Cognetivity Neurosciences Ltd. in December 2017. Its main offices are situated in Vancouver, Canada.

Market snapshot

Symbol
CGNSF
Price
$0.00
Day change
0.00%
Market cap
$895.9K
P/E ratio
-0.13x
52-week range
0.0001-0.0019
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 12 days

Peer companies

  • BioLife Sciences Inc. (BLFE)
  • Banyan Corp. (BNYN)
  • CBD Life Sciences Inc. (CBDL)
  • Electromedical Technologies, Inc. (EMED)
  • Easy Technologies Inc. (EMYSF)
  • Hemp Naturals, Inc. (HPMM)
  • Invion Limited (IVIXF)
  • Rimrock Gold Corp. (RMRK)

Open Cognetivity Neurosciences Ltd. (CGNSF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.